Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
  1. 2020
  2. Published

    The Prosigna 50-gene profile and responsiveness to adjuvant anthracycline-based chemotherapy in high-risk breast cancer patients

    Jensen, M-B., Lænkholm, A-V., Balslev, E., Buckingham, W., Ferree, S., Glavicic, V., Dupont Jensen, J., Søegaard Knoop, A., Mouridsen, H. T., Nielsen, D., Nielsen, T. O. & Ejlertsen, B., 2020, In : Current Medical Literature. Breast Cancer. 6, p. 7

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. 2018
  4. Published

    Is DBCG abreast of new developments?

    Offersen, B. V., Ejlertsen, B., Balslev, E., Flyger, H., Gerdes, A-M., Hansen, M. K., Hølmich, L. R., Jensen, M-B., Kristensen, B., Laenkholm, A-V., Mouridsen, H. T., Nielsen, M. H., Overgaard, J., Tuxen, M., Vejborg, I. & Christiansen, P., Jan 2018, In : Acta oncologica . 57, 1, p. 1-2 2 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Forty years of landmark trials undertaken by the Danish Breast Cancer Cooperative Group (DBCG) nationwide or in international collaboration

    Ejlertsen, B., Offersen, B. V., Overgaard, J., Christiansen, P., Jensen, M-B., Kroman, N., Knoop, A. S. & Mouridsen, H., 2018, In : Acta oncologica . 57, 1, p. 3-12

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Provision of data from the clinical database and of biological material from the tumor bank of the Danish Breast Cancer Cooperative Group 2008-2017

    Mouridsen, H., Christiansen, P., Jensen, M-B., Laenkholm, A-V., Flyger, H., Offersen, B., Vejborg, I. & Ejlertsen, B., 2018, In : Acta oncologica . 57, 1, p. 154-156

    Research output: Contribution to journalLetterResearchpeer-review

  7. Published

    The clinical database and implementation of treatment guidelines by the Danish Breast Cancer Cooperative Group in 2007-2016

    Jensen, M-B., Laenkholm, A-V., Offersen, B. V., Christiansen, P., Kroman, N., Mouridsen, H. T. & Ejlertsen, B., 2018, In : Acta oncologica . 57, 1, p. 13-18

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    The occurrence of fractures after adjuvant treatment of breast cancer: a DBCG register study

    Kristensen, B., Ejlertsen, B., Jensen, M-B., Mouridsen, H. T. & Danish Breast Cancer Cooperative Group, 2018, In : Acta oncologica . 57, 1, p. 141-145

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published
  10. 2017
  11. Published

    Adjuvant Cyclophosphamide and Docetaxel With or Without Epirubicin for Early TOP2A-Normal Breast Cancer: DBCG 07-READ, an Open-Label, Phase III, Randomized Trial

    Ejlertsen, B., Tuxen, M. K., Jakobsen, E. H., Jensen, M-B., Knoop, A. S., Højris, I., Ewertz, M., Balslev, E., Danø, H., Vestlev, P. M., Kenholm, J., Nielsen, D. L., Bechmann, T., Andersson, M., Cold, S., Nielsen, H. M., Maae, E., Carlsen, D. & Mouridsen, H. T., Aug 2017, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 35, 23, p. 2639-2646

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. Published

    Prognostic and predictive importance of the estrogen receptor coactivator AIB1 in a randomized trial comparing adjuvant letrozole and tamoxifen therapy in postmenopausal breast cancer: the Danish cohort of BIG 1-98

    Alkner, S., Jensen, M-B. R., Rasmussen, B. B., Bendahl, P-O., Fernö, M., Ryden, L., Mouridsen, H. & Danish Breast Cancer Cooperative Group, 2017, In : Breast Cancer Research and Treatment. 166, 2, p. 481-490

    Research output: Contribution to journalJournal articleResearchpeer-review

  13. 2016
  14. Published

    Improvements in breast cancer survival between 1995 and 2012 in Denmark: The importance of earlier diagnosis and adjuvant treatment

    Jensen, M-B., Ejlertsen, B., Mouridsen, H. T., Christiansen, P. & Danish Breast Cancer Cooperative Group, Jun 2016, In : Acta oncologica . 55 Suppl 2, p. 24-35 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  15. Published

    Danish Breast Cancer Cooperative Group

    Christiansen, P., Ejlertsen, B., Jensen, M-B. & Mouridsen, H., 2016, In : Clinical Epidemiology. 8, p. 445-449 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  16. 2013
  17. Published
  18. 2012
  19. Published

    Prognostic and predictive role of ESR1 status for postmenopausal patients with endocrine-responsive early breast cancer in the Danish cohort of the BIG 1-98 trial

    Ejlertsen, B., Aldridge, J., Nielsen, K. V., Regan, M. M., Henriksen, K. L., Lykkesfeldt, A., Müller, S., Gelber, R. D., Price, K. N., Rasmussen, B. B., Viale, G., Mouridsen, H. & for the Danish Breast Cancer Cooperative Group, the BIG 1-98 Collaborative Group and the International Breast Cancer Study Group, 10 Oct 2012, In : Annals of Oncology. 23, 5, p. 1138-1144

    Research output: Contribution to journalJournal articleResearchpeer-review

  20. Published

    Lack of independent prognostic and predictive value of centromere 17 copy number changes in breast cancer patients with known HER2 and TOP2A status

    Nielsen, K. V., Ejlertsen, B., Møller, S., Jensen, M-B., Balslev, E., Müller, S., Knoop, A. & Mouridsen, H. T., 2012, In : Molecular Oncology. 6, 1, p. 88-97 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  21. 2011
  22. Published

    HER2 and TOP2A as predictive markers for anthracycline-containing chemotherapy regimens as adjuvant treatment of breast cancer: a meta-analysis of individual patient data

    Di Leo, A., Desmedt, C., Bartlett, J. M. S., Piette, F., Ejlertsen, B., Pritchard, K. I., Larsimont, D., Poole, C., Isola, J., Earl, H., Mouridsen, H., O'Malley, F. P., Cardoso, F., Tanner, M., Munro, A., Twelves, C. J., Sotiriou, C., Shepherd, L., Cameron, D., Piccart, M. J., Buyse, M. & HER2/TOP2A Meta-analysis Study Group, Nov 2011, In : Lancet Oncology. 12, 12, p. 1134-42 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  23. Published

    Dose-tailoring of FEC adjuvant chemotherapy based on leukopenia is feasible and well tolerated. Toxicity and dose intensity in the Scandinavian Breast Group phase 3 adjuvant Trial SBG 2000-1

    Edlund, P., Ahlgren, J., Bjerre, K., Andersson, M., Bergh, J., Mouridsen, H., Holmberg, S. B., Bengtsson, N-O., Jakobsen, E. W., Møller, S., Lindman, H. & Blomqvist, C., Apr 2011, In : Acta Oncologica. 50, 3, p. 329-37 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  24. Published

    Analyses adjusting for selective crossover show improved overall survival with adjuvant letrozole compared with tamoxifen in the BIG 1-98 study

    Colleoni, M., Giobbie-Hurder, A., Regan, M. M., Thürlimann, B., Mouridsen, H., Mauriac, L., Forbes, J. F., Paridaens, R., Láng, I., Smith, I., Chirgwin, J., Pienkowski, T., Wardley, A., Price, K. N., Gelber, R. D., Coates, A. S. & Goldhirsch, A., Mar 2011, In : Journal of Clinical Oncology. 29, 9, p. 1117-24 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  25. Published

    Amplification of ESR1 may predict resistance to adjuvant tamoxifen in postmenopausal patients with hormone receptor positive breast cancer

    Nielsen, K. V., Ejlertsen, B., Müller, S., Møller, S., Rasmussen, B., Balslev, E., Lænkholm, A-V., Christiansen, P. M. & Mouridsen, H. T., 2011, In : Breast Cancer Research and Treatment. 127, 2, p. 345-55 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  26. Published

    Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark

    Christiansen, P. M., Bjerre, K., Ejlertsen, B., Jensen, M-B., Rasmussen, B. B., Lænkholm, A-V., Kroman, N., Ewertz, M., Offersen, B. V., Toftdahl, D. B., Møller, S., Mouridsen, H. T. & Danish Breast Cancer Cooperative Group, 2011, In : National Cancer Institute. Journal (Print). 103, 18, p. 1363-72 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  27. Published

    Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial

    Viale, G., Regan, M. M., Dell'Orto, P., Mastropasqua, M. G., Maiorano, E., Rasmussen, B. B., MacGrogan, G., Forbes, J. F., Paridaens, R. J., Colleoni, M., Láng, I., Thürlimann, B., Mouridsen, H., Mauriac, L., Gelber, R. D., Price, K. N., Goldhirsch, A., Gusterson, B. A., Coates, A. S. & BIG 1-98 Collaborative and International Breast Cancer Study Groups, 2011, In : Annals of Oncology. 22, 10, p. 2201-7 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  28. 2010
  29. Published

    CEF is superior to CMF for tumours with TOP2A aberrations: a Subpopulation Treatment Effect Pattern Plot (STEPP) analysis on Danish Breast Cancer Cooperative Group Study 89D

    Gunnarsdóttir, K. A., Jensen, M-B., Zahrieh, D., Gelber, R. D., Knoop, A., Bonetti, M., Mouridsen, H. & Ejlertsen, B., 1 Aug 2010, In : Breast Cancer Research and Treatment. 123, 1, p. 163-9 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  30. Published

    HER2, TOP2A, and TIMP-1 and responsiveness to adjuvant anthracycline-containing chemotherapy in high-risk breast cancer patients

    Ejlertsen, B., Jensen, M-B., Nielsen, K., Balslev, E., Rasmussen, B., Willemoe, G. L., Hertel, P. B., Knoop, A. S., Mouridsen, H. T. & Brünner, N. A., 20 Feb 2010, In : Journal of Clinical Oncology. 28, 6, p. 984-90 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  31. Published

    Cyclophosphamide, methotrexate, and fluorouracil; oral cyclophosphamide; levamisole; or no adjuvant therapy for patients with high-risk, premenopausal breast cancer

    Ejlertsen, B., Mouridsen, H. T., Jensen, M. B., Andersen, J., Andersson, M., Kamby, C. & Knoop, A., 2010, In : Cancer. 116, 9, p. 2081-9 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  32. 2008
  33. Published

    Prognostic effect of estrogen receptor status across age in primary breast cancer

    Bentzon, N., Düring, M., Rasmussen, B. B., Mouridsen, H. & Kroman, N., 1 Mar 2008, In : Radiation Oncology Investigations. 122, 5, p. 1089-94 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  34. 2006
  35. Published

    Chemotherapy versus ovarian ablation as adjuvant therapy for breast cancer: impact on health-related quality of life in a randomized trial

    Groenvold, M., Fayers, P. M., Petersen, M. A. & Mouridsen, H. T., Aug 2006, In : Breast Cancer Research and Treatment. 98, 3, p. 275-84 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  36. 2005
  37. Published

    Towards discovery-driven translational research in breast cancer

    Celis, J. E., Moreira, J. M. A., Gromova, I., Cabezon, T., Ralfkiaer, U., Guldberg, P., Straten, P. T., Mouridsen, H., Friis, E., Holm, D. K., Rank, F. & Gromov, P., Jan 2005, In : The F E B S Journal (Online). 272, 1, p. 2-15 14 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  38. 1993
  39. Published

    A novel method for monitoring high-risk breast cancer with tumor markers: CA 15.3 compared to CEA and TPA

    Sölétormos, G., Nielsen, D., Schiøler, V., Skovsgaard, T., Winkel, P., Mouridsen, H. T. & Dombernowsky, P., Dec 1993, In : Annals of Oncology. 4, 10, p. 861-9 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 11979